selected scholarly activity
-
academic article
- Improving the inclusion of transgender and nonbinary individuals in the planning, completion, and mobilization of cardiovascular research. American Journal of Physiology - Heart and Circulatory Physiology. 324:H366-H372. 2023
- Plasma Exchange for ANCA-Associated Vasculitis: An International Survey of Patient Preferences. Kidney Medicine. 5:100595-100595. 2023
- Sex and Gender in Randomized Controlled Trials of Adults Receiving Maintenance Dialysis: A Meta-epidemiologic Study. AMERICAN JOURNAL OF KIDNEY DISEASES. S0272-6386(22)01078-2. 2022
- Gender-affirming estrogen therapy route of administration and cardiovascular risk: a systematic review and narrative synthesis. American Journal of Physiology - Heart and Circulatory Physiology. 323:H861-H868. 2022
- Underrepresentation of Women in Recent Landmark Kidney Trials: The Gender Gap Prevails. Kidney International Reports. 7:2526-2529. 2022
- Metabolic Acidosis is Associated With Acute Kidney Injury in Patients With CKD. Kidney International Reports. 7:2219-2229. 2022
- Patient Navigators for CKD and Kidney Failure: A Systematic Review. Kidney Medicine. 4:100540-100540. 2022
- The Effect of Gender-Affirming Hormone Therapy on Measures of Kidney Function. Clinical journal of the American Society of Nephrology : CJASN. 17:1305-1315. 2022
- Prescription patterns of sodium and calcium polystyrene sulfonate in patients with hyperkalemia and chronic kidney disease receiving RAAS inhibitors. CKJ: Clinical Kidney Journal. 15:1713-1719. 2022
- Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study. AMERICAN JOURNAL OF KIDNEY DISEASES. 80:164-173.e1. 2022
- Association of metabolic acidosis with fractures, falls, protein-calorie malnutrition and failure to thrive in patients with chronic kidney disease. CKJ: Clinical Kidney Journal. 15:1379-1386. 2022
- Cannabinoids for Symptom Management in Patients with Kidney Failure. Clinical journal of the American Society of Nephrology : CJASN. 17:911-921. 2022
- Impact of quality improvement initiatives to improve CKD referral patterns: a systematic review protocol. BMJ Open. 12:e055456-e055456. 2022
- Chronic Kidney Disease in the Transgender, Nonbinary, or Gender Diverse Person. Seminars in Nephrology. 42:129-141. 2022
- Targeting the opioid pathway for the treatment of chronic kidney disease‐associated pruritus: a systematic review and meta‐analysis of randomized controlled trials. British Journal of Dermatology. 186:575-577. 2022
- Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a clinical practice guideline. British Medical Journal BMJ (Clinical research ed.). 376:e064597-e064597. 2022
- The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis. British Medical Journal BMJ (Clinical research ed.). 376:e064604-e064604. 2022
- Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study. BMC Nephrology. 22:185. 2021
- Response to Weinfurt and Cappelleri on “Patient reported outcome measures in clinical trials should be initially analyzed as continuous outcomes for statistical significance and responder analyses should be reserved as secondary analyses”. Journal of Clinical Epidemiology. 140:1-2. 2021
- Coming full circle: patient and physician reunite in kidney research network. CMAJ. 193:E1693-E1694. 2021
- Metabolic Acidosis and Cardiovascular Disease in CKD. Kidney Medicine. 3:753-761.e1. 2021
- Three week compared to seven week run-in period length and the assessment of pre-randomization adherence: A study within a trial. Controlled Clinical Trials Contemporary Clinical Trials. 107:106466-106466. 2021
- Patient reported outcome measures in clinical trials should be initially analyzed as continuous outcomes for statistical significance and responder analyses should be reserved as secondary analyses. Journal of Clinical Epidemiology. 134:95-102. 2021
- Mineralocorticoid Receptor Antagonists in CKD: In Need of a Few Large Trials. AMERICAN JOURNAL OF KIDNEY DISEASES. 77:813-815. 2021
- Effect of Aerobic Exercise on Dialysis-Related Symptoms in Individuals Undergoing Maintenance Hemodialysis. Clinical journal of the American Society of Nephrology : CJASN. 16:560-574. 2021
- Nephrologist Views Regarding Cannabinoid Use in Advanced Chronic Kidney Disease and Dialysis: A Survey. Journal of Pain and Symptom Management. 61:237-245.e2. 2021
- Variability in Cardiac Biomarkers during Hemodialysis: A Prospective Cohort Study. Clinical Chemistry. 67:308-316. 2021
- Providing Care for Transgender Persons With Kidney Disease: A Narrative Review. Canadian Journal of Kidney Health and Disease. 8:205435812098537-205435812098537. 2021
- Response to “Assessment of Renal Function in Transgender Patients With Kidney Disease”. Canadian Journal of Kidney Health and Disease. 8:205435812110201-205435812110201. 2021
- The Kidney Check program – championing patient-centered, culturally safe, preventive kidney care in Canada’s rural and remote Indigenous communities. eJIFCC - electronic Journal of the International Federation of Clinical Chemistry and Laboratory Medicine. 32:61-68. 2021
- Prerandomization run-in periods in randomized controlled trials of chronic diseases: a methodological study. Journal of Clinical Epidemiology. 128:148-156. 2020
- Recent advances in the treatment of uremic pruritus. Current Opinion in Nephrology and Hypertension. 29:465-470. 2020
- The DIalysis Symptom COntrol-Restless Legs Syndrome (DISCO-RLS) Trial: A Protocol for a Randomized, Crossover, Placebo-Controlled Blinded Trial. Canadian Journal of Kidney Health and Disease. 7:205435812096895-205435812096895. 2020
- Post-PIVOTAL Iron Dosing with Maintenance Hemodialysis. Clinical journal of the American Society of Nephrology : CJASN. 14:1533-1535. 2019
- Screening questions for the diagnosis of restless legs syndrome in hemodialysis. CKJ: Clinical Kidney Journal. 12:559-563. 2019
- The Fracture Risk Assessment Tool (FRAX®) predicts fracture risk in patients with chronic kidney disease. Kidney International. 95:447-454. 2019
- Canadian Nephrologist Views Regarding Stroke and Systemic Embolism Prevention in Dialysis Patients With Nonvalvular Atrial Fibrillation: A Survey. Canadian Journal of Kidney Health and Disease. 6:205435811882194-205435811882194. 2019
- Multidisciplinary Chronic Kidney Disease Clinic Practices: A Scoping Review. Canadian Journal of Kidney Health and Disease. 6:205435811988266-205435811988266. 2019
- Roadblocks and Opportunities to the Implementation of Novel Therapies for Acute Kidney Injury: A Narrative Review. Canadian Journal of Kidney Health and Disease. 6:205435811988051-205435811988051. 2019
- Single Questions for the Screening of Anxiety and Depression in Hemodialysis. Canadian Journal of Kidney Health and Disease. 6:205435811882544-205435811882544. 2019
- Conventional Risk Factors Associated With Meaningful Outcomes in Advanced CKD. Kidney International Reports. 3:513-515. 2018
- Fracture risk and treatment in chronic kidney disease. Current Opinion in Nephrology and Hypertension. 27:221-225. 2018
- Safety of Intravenous Iron in Dialysis. Clinical journal of the American Society of Nephrology : CJASN. 13:457-467. 2018
- Health Care Costs Associated with AKI. Clinical journal of the American Society of Nephrology : CJASN. 12:1733-1743. 2017
- A Scoping Review for Strategies to Increase Living Kidney Donation. Clinical journal of the American Society of Nephrology : CJASN. 12:1518-1527. 2017
- In-Center Nocturnal Hemodialysis Versus Conventional Hemodialysis: A Systematic Review of the Evidence. AMERICAN JOURNAL OF KIDNEY DISEASES. 70:218-234. 2017
- A Methanol Intoxication Outbreak From Recreational Ingestion of Fracking Fluid. AMERICAN JOURNAL OF KIDNEY DISEASES. 69:696-700. 2017
- Anemia management in chronic kidney disease and dialysis. Current Opinion in Nephrology and Hypertension. 26:214-218. 2017
- ANCA Associated Vasculitis Secondary to Levamisole-Adultered Cocaine with Associated Membranous Nephropathy: A Case Series. American Journal of Nephrology. 45:209-216. 2017
- The Patterns, Risk Factors, and Prediction of Progression in Chronic Kidney Disease: A Narrative Review. Seminars in Nephrology. 36:273-282. 2016
- The Effect of Erythropoietin-Stimulating Agents on Health-Related Quality of Life in Anemia of Chronic Kidney Disease. Annals of Internal Medicine. 164:472-472. 2016
- Perspectives on Optimizing Care of Patients in Multidisciplinary Chronic Kidney Disease Clinics. Canadian Journal of Kidney Health and Disease. 3:122-122. 2016
- Light and COP1 regulate level of overexpressed DET1 protein. Plant Science. 231:114-123. 2015
- An Economic Assessment Model of Rural and Remote Satellite Hemodialysis Units. PLoS ONE. 10:e0135587-e0135587. 2015
- Creating a model for improved chronic kidney disease care: designing parameters in quality, efficiency and accountability. Nephrology Dialysis Transplantation. 25:3623-3630. 2010
-
chapter
-
conference paper
- The Steroid Tapering in ANCA Vasculitis Evaluation Study (STAVE) 2: A Systematic Review and Meta-Analysis. Arthritis and Rheumatology. 2017
- THE STEROID TAPERING IN ANCA VASCULITIS EVALUATION STUDY (STAVE) 2: A SYSTEMATIC REVIEW AND META-ANALYSIS. Rheumatology. 103-103. 2017